Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease

Real-life data on interferon (IFN)-free direct acting antiviral (DAA) therapies for chronic hepatitis C (CHC) is limited for Asian Americans. To evaluate sustained virologic response (SVR) and adverse events (AE) in Asian Americans treated with sofosbuvir (SOF)-based, IFN-free DAA therapies. This is...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Christine Y., Nguyen, Pauline, Le, An, Zhao, Changqing, Ahmed, Aijaz, Daugherty, Tami, Garcia, Gabriel, Lutchman, Glen, Kumari, Radhika, Nguyen, Mindie H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313031/
https://www.ncbi.nlm.nih.gov/pubmed/28178174
http://dx.doi.org/10.1097/MD.0000000000006128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313031/
https://www.ncbi.nlm.nih.gov/pubmed/28178174
http://dx.doi.org/10.1097/MD.0000000000006128

Ejemplares similares